LONDON–(BUSINESS WIRE)–The global ENT disorder treatment market is expected to grow by USD 1.32 billion as per Technavio. This marks a significant market slow down compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of over 1%.
Request challenges and opportunities that influence COVID-19 pandemic – Request Free Sample Report on COVID-19 Impacts
Read the 120-page report with TOC on “ENT Disorder Treatment Market Analysis Report by Indication (Rhinitis, Sinusitis, Otitis media, and Tonsillitis), Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024”.
https://www.technavio.com/report/ent-disorder-treatment-market-size-industry-analysis
The market is driven by rapid environmental deterioration resulting in several allergic conditions. In addition, advances in research on allergic disorders are anticipated to boost the growth of the ENT disorder treatment market.
The global air pollution levels have significantly increased over the past decade, which has exposed a majority of the population to poor air conditions. This can be attributed to the increasing use of chemical substances, especially in the agriculture and manufacturing industries. For instance, people in highly industrialized cities such as New Delhi and Beijing are more prone to chronic sinusitis due to the extreme levels of pollutants in the air. Moreover, the rising use of fossil fuels in various industries has increased the presence of harmful gases such as nitric oxide, carbon monoxide, and sulfur dioxide in the air. Many such factors are increasing the prevalence of various allergic conditions, including ENT disorders, which is driving the growth of the global ENT disorder treatment market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five ENT Disorder Treatment Companies:
AbbVie Inc.
AbbVie Inc. operates its business through the Unified Business segment. The company offers Acarizax, which is an allergy immunotherapy tablet used for the treatment of rhinitis caused due to the signs and symptoms of house dust mite.
ALK-Abello AS
ALK-Abello AS operates its business through the Unified business segment. The company offers products such as Grazax and ACARIZAX for the treatment of ENT disorders.
Bayer AG
Bayer AG offers Claritin. This is an allergy immunotherapy that offers allergy relief and relieves sinus pressure for kids and adults.
Covis Pharma BV
Covis Pharma BV operates its business through segments such as Respiratory and Allergy, Cardiovascular, Gastroenterology and CNS, and Authorized Generics. The company offers products such as ALVESCO, OMNARIS, ZETONNA for the treatment of ENT disorders.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. operates its business through segments such as Pharmaceuticals and Diagnostics. The company offers Bactrim (sulfamethoxazole and trimethoprim). This is a synthetic antibacterial combination product used to treat sinusitis caused due to bacterial infections.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
ENT Disorder Treatment Market Indication Outlook (Revenue, USD Billion, 2020-2024)
- Rhinitis
- Sinusitis
- Otitis media
- Tonsillitis
ENT Disorder Treatment Market Geography Outlook (Revenue, USD Billion, 2020-2024)
- North America
- Europe
- Asia
- ROW
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.
Related Reports on Healthcare Include:
Global ENT Devices Market – Global ENT devices market by product (diagnostic ENT devices, surgical ENT devices, hearing implants, voice prosthetics, and nasal splints) and geography (APAC, Europe, MEA, North America, and South America).
Global ENT Laser Devices Market – Global ENT laser devices market by product (gas lasers and solid and semiconductor-based lasers) and geography (North America, Europe, Asia, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
